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Abstract
Importance
Altered neurodevelopmental trajectories are thought to reflect heterogeneity in the pathophysiologic
characteristics of schizophrenia, but whether neural indicators of these trajectories are associated with
future psychosis is unclear.
Objective
To investigate distinct neuroanatomical markers that can differentiate aberrant neurodevelopmental
trajectories among clinically high-risk (CHR) individuals.
Design, Setting, and Participants
In this prospective longitudinal multicenter study, a neuroanatomical-based age prediction model was
developed using a supervised machine learning technique with T1-weighted magnetic resonance imaging
scans of 953 healthy controls 3 to 21 years of age from the Pediatric Imaging, Neurocognition, and
Genetics (PING) study and then applied to scans of 275 CHR individuals (including 39 who developed
psychosis) and 109 healthy controls 12 to 21 years of age from the North American Prodrome
Longitudinal Study 2 (NAPLS 2) for external validation and clinical application. Scans from NAPLS 2
were collected from January 15, 2010, to April 30, 2012.
Main Outcomes and Measures
Discrepancy between neuroanatomical-based predicted age (hereafter referred to as brain age) and
chronological age.
Results
The PING-derived model (460 females and 493 males; age range, 3-21 years) accurately estimated the
chronological ages of the 109 healthy controls in the NAPLS 2 (43 females and 66 males; age range, 12-21
years), providing evidence of independent external validation. The 275 CHR individuals in the NAPLS 2
(111 females and 164 males; age range, 12-21 years) showed a significantly greater mean (SD) gap
between model-predicted age and chronological age (0.64 [2.16] years) compared with healthy controls (P 
= .008). This outcome was significantly moderated by chronological age, with brain age systematically
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overestimating the ages of CHR individuals who developed psychosis at ages 12 to 17 years but not the
brain ages of those aged 18 to 21 years. Greater brain age deviation was associated with a higher risk for
developing psychosis (F = 3.70; P = .01) and a pattern of stably poor functioning over time, but only
among younger CHR adolescents. Previously reported evidence of accelerated reduction in cortical
thickness among CHR individuals who developed psychosis was found to apply only to those who were 18
years of age or older.
Conclusions and Relevance
These results are consistent with the view that neuroanatomical markers of schizophrenia may help to
explain some of the heterogeneity of this disorder, particularly with respect to early vs later age of onset of
psychosis, with younger and older individuals having differing intercepts and trajectories in structural
brain parameters as a function of age. The results also suggest that baseline neuroanatomical measures are
likely to be useful in estimating onset of psychosis, especially (or only) among CHR individuals with an
earlier age of onset of prodromal symptoms.
Key Points
Question
Are deviations from the normal neuroanatomical maturation pattern associated with future psychosis
among clinically high-risk individuals?
Findings
In this longitudinal multicenter study, clinically high-risk individuals between 12 and 17 years of age
showed exaggerated deviation in neuroanatomical maturity at the time of baseline evaluation, which in
turn was associated with a greater risk for developing psychosis and a pattern of stably poor functioning,
while accelerated reduction in cortical thickness among clinically high-risk individuals who developed
psychosis was found to apply only to those who were 18 years of age or older.
Meaning
Clinically high-risk individuals expressing prodromal symptoms of psychosis in early adolescence show
contemporaneous signs of neuroanatomical vulnerability, which may be useful for estimating onset of
psychosis.
Introduction
Both early (prenatal and perinatal) and late (adolescent) neurodevelopmental disturbances are
hypothesized to play a role in the abnormalities of brain structure and function associated with
schizophrenia.  Disturbances originating earlier in life (eg, resulting from the interplay of genetic factors
and obstetric complications) would be expected to affect brain integrity from birth onward and could
therefore help to explain children with subtle motor, cognitive, and social-affective deficits during
childhood and earlier ages at onset of full psychosis (ie, early to mid-teens).  In
contrast, disturbances that emerge during late adolescence and early adulthood (eg, via abnormal
neuromaturational events and/or environmental factors) could help to explain individuals with normal
premorbid psychological health and a more acute onset of psychotic symptoms and functional impairment
in the late teens and early 20s.  Although these 2 sets of processes likely co-occur in at least
some cases, in isolation they lead to differential estimations concerning the extent to which
neuroanatomical measures can aid in the detection of risk for psychosis prior to onset (Figure 1).
Specifically, individuals who are relatively more affected by early neurodevelopmental disturbances would
be expected to manifest greater neuroanatomical deviation relative to age-matched peers prior to onset of
1,2
1,3,4,5,6,7,8,9,10,11,12,13
1,2,13,14,15,16,17
1,2,18,19
6
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psychosis,  while those who are relatively more affected by later neurodevelopmental disturbances
would be expected to be neuroanatomically similar to age-matched peers throughout most of the
premorbid period but to show a rapidly increasing deviation prior to the onset of psychosis.
Consistent with the theoretical framework just outlined, prior work has observed a general pattern of
greater neuroanatomical compromise among patients with schizophrenia who have a history of early-life
risk exposures (eg, obstetric complications) and/or an earlier age at onset of schizophrenia.
However, these cross-sectional case-control studies cannot comment on the timing of the appearance or
course of the neuroanatomical changes or their potential relevance to estimation of onset of psychosis. To
address these questions more definitively, prospective longitudinal evaluation is required.
Here, we relied on the early vs late neurodevelopmental influences model to guide our set of hypotheses,
given that this model makes differential estimations related to the timing of onset of psychosis in
association with different trajectories of neurodevelopmental disturbances. To quantify deviation from a
normative neuromaturational trajectory on an individual basis, we sought a computationally efficient
method to capture variance in a comprehensive set of neuroanatomical measures most sensitive to age-
related differences using a machine learning approach. Prior studies using this method have yielded “brain
age” estimates based on magnetic resonance imaging (MRI) scans that closely track with the true
chronological ages of typically developing individuals.  Such a metric has been shown to be highly
replicable,  heritable,  and robust to confounders, such as scanner-related noise  and
head motion.
Prior studies of adult samples of patients with schizophrenia have applied this framework to show a pattern
of accelerated brain aging in the patient groups compared with controls.  However, it remains
unknown whether greater deviation in neuroanatomical maturity is associated with clinical outcomes in
adolescents and young adults with a risk of psychosis. In this study, we generated a neuroanatomical-based
age prediction model using the Pediatric Imaging, Neurocognition, and Genetics (PING) study MRI data
set, which consists of scans from typically developing individuals across a wide age range from childhood
to early adulthood.  We then validated the PING-derived model in application to the baseline MRI
scans of the healthy controls (HCs) and individuals at clinically high risk (CHR) at the baseline evaluation
in the North American Prodromal Longitudinal Study 2 (NAPLS 2) sample.
We hypothesized that the PING-derived model would accurately predict individuals’ chronological ages
when applied to the scans from the healthy cohort in the NAPLS 2, providing evidence of independent
external validation. We then used the validated model to test our primary hypotheses that CHR individuals
who were younger at the time of ascertainment (as a proxy for an earlier age at onset of prodromal
symptoms) will show an estimated neuroanatomical-based predicted age older than their chronological
ages and that this greater deviation in neuroanatomical maturity will be associated with a greater risk for
developing psychosis and a pattern of stably poor functioning during 1 year of follow-up.
Methods
The current study was approved by expedited review by the Yale University Human Subjects Committee.
The study protocol and consent form were reviewed and approved by the institutional review boards at
each of the 8 participating data collection sites (University of California, Los Angeles; Emory University;
Harvard Medical School; Zucker Hillside Hospital; University of North Carolina; University of California,
San Diego; University of Calgary; and Yale University). All participants provided written informed
consent.
PING Cohort
5,6
1,2,14,17
5,6,7,9,20
21,22
23,24,25,26,27,28,29 23 24,26
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25,27
21,30
14,31
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Publicly available PING data were obtained through the PING portal (http://pingstudy.ucsd.edu) and used
for building multivariate models predicting chronological age in typically developing individuals using
their T1-weighted MRI scans (N = 953; 3-21 years of age).
NAPLS 2 Cohort
Clinically high-risk individuals and their matched HCs were recruited through the NAPLS 2 Consortium,
which consisted of 8 sites in North America studying the prodrome period of psychosis.  The CHR
individuals were assessed based on the Structured Interview for Psychosis Risk Syndromes.
The NAPLS 2 participants included in this study were those with T1-weighted MRI scans available who
were between 12 and 21 years of age at the baseline assessment. Scans from NAPLS 2 were collected from
January 15, 2010, to April 30, 2012. In total, 39 CHR individuals developed psychosis (“converted”;
CHR-C), 236 CHR individuals did not convert to psychosis (CHR-NC), and 109 were HCs. The
demographic characteristics of the 3 groups are shown in the Table (see eAppendix in the Supplement and
previous publications for additional details about the PING  and NAPLS 2  Consortia).
Neuroimaging Data Acquisition and Image Processing
High-resolution, T1-weighted brain images were acquired using 3-T scanners for PING and NAPLS 2.
Image postprocessing steps were performed using the FreeSurfer software suite, version 5.3
(http://surfer.nmr.mgh.harvard.edu/)  (eAppendix in the Supplement).
Multivariate Modeling for Estimating Age
We preselected a limited number of neuroanatomical measures (N = 92) to minimize redundant
information, yet we included volume measures from all parcels provided by the Desikan atlas  (see
eTable 1 in the Supplement for a complete list). Prior to model fitting, sex differences and scanner-specific
offsets were estimated per predictor and adjusted using a linear mixed model. For model training, we used
penalized regression with L  norms (ridge regression) to avoid overfitting.  For simplicity, the predicted
age from neuroanatomical measures will be referred to as the brain age. The deviation of the predicted age
from the individuals’ chronological age (brain age − chronological age) will be referred as the brain age
gap. To directly compare the magnitude of the brain age gap across the full age range, the bias was
estimated and accounted for in the model (see eAppendix, eFigure 1, and eFigure 2 in the Supplement for
methodological details).
Model Training, Validation, and Application
All structural scans available from the PING data set were used as the discovery data set to build a model
estimating individuals’ true ages. A repeated, nested cross-validation method was used to optimize the
tuning parameter λ and derive unbiased estimates of model performance, which were evaluated by
minimizing the mean absolute error (MAE).  For the purpose of assessing generalizability, the PING-
derived model was then applied without modification to the baseline MRI data of the HCs and CHR
individuals from NAPLS 2 and adolescents with a first episode of psychosis (n = 14) as an additional
external validation test (eAppendix in the Supplement).
Association With Clinical Measures
We examined associations between brain age gap and prodromal status based on the Structured Interview
for Psychosis Risk Syndromes  and the Global Assessment of Functioning Scale  as an index of overall
functioning assessed at baseline and 12-month follow-up or at conversion to psychosis.
Statistical Analysis
31
32
21,30 14,31,33
34,35,36,37
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To compare brain age across groups, the generalized linear model was used with chronological age, group,
and chronological age × group interaction as independent variables. When a chronological age × group
interaction was detected, secondary analyses were performed on the brain age gap using analysis of
variance when clinical samples were partitioned into younger (12-17 years of age) and older adolescents
(18-21 years of age) because the deflection point underlying a significant chronological age × group
interaction occurred at around 17 years of age (which is also the median age in the included sample). Age
at baseline evaluation was highly correlated with age at onset of psychosis among individuals who
converted (eFigure 3 in the Supplement) because most developed full-blown psychotic symptoms in less
than a year from ascertainment. A receiver operating characteristic analysis was used to estimate
classification accuracy between CHR-C and CHR-NC individuals using the brain age gap as the sole
predictor. For post hoc t tests, a Bonferroni correction was applied for multiple comparisons as noted.
Statistical tests were 2-sided with significance set at P < .05.
Results
Brain Age Model Performance and External Validation
Magnetic resonance imaging scans of typically developing individuals from the PING cohort (n = 953; age
range, 3-21 years; 460 females and 493 males) were used for the model training phase. Then, the validated
PING-derived model was applied to MRI scans of the HCs (n = 109; age range, 12-21 years; 43 females
and 66 males) and CHR individuals (n = 275; age range, 12-21 years; 111 females and 164 males) in the
NAPLS 2 sample for external validation and clinical application. The models built using the cross-
validation procedure in the PING cohort explained 84% of the chronological age variance (P < .001) with
an MAE of 1.69 years (Figure 2A). When this PING-derived model was applied to an independent
external data set (ie, the HC group in the NAPLS 2 cohort), it accounted for 51% of the variance (P < .001)
in chronological age, with an MAE of 1.41 years (Figure 2B). This degree of generalizability is
comparable to the cross-validation results within the PING sample when the age range was restricted to
match that of the NAPLS 2 sample (age range, 12-21 years; n = 449; MAE = 1.55; R  = 65%; P < .001).
See eTable 2 in the Supplement for model parameters.
Association of Psychosis Risk With Brain Age Gap
Next, the validated brain age model was applied to CHR individuals. Overall, the CHR group showed a
significantly increased mean (SD) brain age gap (0.64 [2.16] years) compared with HCs (P = .008). As
shown in Figure 2B, a significant chronological age × CHR group interaction (t = –1.99; P = .047) was
observed, whereby brain age was systematically overestimated among younger adolescents (≤17 years of
age) in both CHR-C and CHR-NC individuals but not among those 18 years of age or older. To further
characterize chronological age as a potential moderating variable, statistical tests were performed for
younger and older adolescents separately, defined using a median split of 17.04 years (eTable 3 in the
Supplement). Among younger adolescents, the mean brain age gap was significantly greater than zero for
CHR-C individuals (1.59 years; P < .001, corrected) and CHR-NC individuals (0.67; P = .004, corrected)
but not for HCs (0.06; P = .99, corrected). Furthermore, the brain age gap differed significantly across
groups for younger adolescents (F = 3.70; P = .01). Post hoc tests revealed that the brain age gap of CHR-
C individuals was significantly higher compared with HCs (1.58 years; P = .02, corrected). The brain age
gap for CHR-NC individuals was also greater than for HCs but not significantly so (0.67 years; P = .15,
corrected). There were no significant differences in brain age gap between groups among older adolescents
(F = 1.09; P = .35).
In the receiver operating characteristic analysis among CHR individuals 17 years of age or younger, the
brain age gap was a significant predictor of conversion to psychosis with an area under the curve of 0.63
(P = .046, permutation test with 5000 iterations; eFigure 4 in the Supplement), and these effects were not
explained by exposure to antipsychotic medication (eFigure 5 in the Supplement).
2
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Brain Age Gap in Adolescents With a First Episode of Psychosis
Adolescents with a first episode of psychosis also exhibited a significantly greater mean brain age gap
compared with their matched controls (1.17 years; P = .001, permutation test). When divided into younger
and older groups based on chronological age and compared with data from the NAPLS 2 cohort, younger
patients with a first episode of psychosis showed a larger brain age gap compared with HCs (1.86 years; P 
= .02, permutation test) but did not significantly differ from CHR-NC individuals or CHR-C individuals.
Generalized linear model analysis revealed a significant linear association of the severity of psychotic
illness with the brain age gap only in younger adolescents (categorical variables ordered as ordinal
variables: HCs < CHR-NC individuals < CHR-C individuals < individuals with a first episode of psychosis;
group as ordinal variable; t = 3.31; P = .001; Figure 2C) and not in older adolescents (Figure 2D).
Association of Brain Age Gap With Global Functioning Outcome
Next, we evaluated the association between brain age gap and Global Assessment of Functioning Scale
scores at baseline and 12-month follow-up or at conversion to psychosis among the CHR individuals from
NAPLS 2. Overall, Global Assessment of Functioning Scale scores assessed at follow-up significantly
improved compared with the baseline scores (t = 6.01; P < .001). The younger adolescent group of CHR
individuals was divided into 3 groups with a threshold set by ±MAE of the brain age model in external
validation. As shown in Figure 3, CHR individuals falling within the expected range showed improved
functioning at follow-up relative to baseline (10.21 points; t = 3.87; P < .001, corrected), whereas the
Global Assessment of Functioning Scale scores of the individuals with a brain age gap beyond ±MAE
showed a stable pattern of poor functioning during this interval. Similar results were observed when CHR-
C individuals were excluded (eFigure 6 in the Supplement).
Prediction of Conversion to Psychosis Among CHR Individuals
In the interest of completeness, we also attempted to use baseline neuroanatomical measures derived from
T1-weighted MRI data to directly predict conversion to psychosis among the NAPLS 2 CHR sample (71
converters and 436 nonconverters) using standard machine learning approaches, but the trained models
derived from our data set did not significantly predict conversion to psychosis (see eAppendix in the
Supplement for methodological details, results, and discussion).
Discussion
In this study, we successfully reproduced a neuroanatomical-based age prediction model using a typically
developing cohort (PING sample) and successfully validated the model in an independent sample (NAPLS
2 HCs). When a validated brain age prediction model is applied to structural MRI data from adolescent
and young adult individuals at CHR for psychosis, the CHR individuals show a systematic overestimation
of brain age that in turn is associated with a higher risk for conversion to psychosis and a pattern of stably
poor functioning. Consistent with the neurodevelopmental framework, these associations were found to be
specific to individuals with earlier ages at onset of prodromal symptoms of psychosis (≤17 years of age)
and also generalized to younger individuals with a first episode of psychosis, possibly representing an
aberrant neurodevelopmental trajectory with a lower y-intercept (Figure 1).  Because the model
primarily fitted cortical gray matter measures with negative weights, older predicted age in these samples
would be generally associated with reduced gray matter structures. This pattern of findings is consistent
with the notion that contemporaneous neuroanatomical vulnerability is characteristic of individuals
expressing prodromal symptoms in early adolescence  and imply that a greater brain age gap may
be useful in prediction of early-onset forms of psychosis.
Progressive Changes in Brain Structures in Converters to Psychosis
1,2,18,19
5,6,7,9,20
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According to the neurodevelopmental framework (Figure 1),  older adolescent and young adult
CHR individuals with more acute-onset forms of psychosis would be expected to show normal brain
maturation premorbidly and an increasing deviation around the time of onset of psychosis.  Prior
studies of longitudinal changes in brain structure in this sample (NAPLS 2) demonstrated an accelerated
rate of cortical thinning in the superior and medial prefrontal regions and a greater rate of expansion of the
third ventricle among CHR individuals who converted to psychosis compared with those who did not and
with HCs.  Age was assessed as a covariate in these studies; the reported outcomes were robust to
age when its effects were “regressed out” in this way. However, given the results of the present
investigation and the predictions of the neurodevelopmental framework (Figure 1),  it may be more
informative to evaluate age as a moderator in such analyses. To do so, we revisited the longitudinal data
and plotted annualized rates of change in these neuroanatomical structures as a function of age at the time
of the baseline scan. As shown in Figure 4,  the differential rates of change in structural brain
parameters among those who converted to psychosis apply only to those who were 18 years of age or older
at baseline. In contrast, among younger individuals (12-17 years of age), the groups did not differ in the
rate of prefrontal cortical thinning or third ventricle expansion.
Given that the neuroanatomical parameters in prefrontal regions undergo robust maturational changes
during later adolescence  and that the converters exhibiting an accelerated rate of cortical
thinning are overrepresented in this age range, CHR individuals with an earlier age at onset of prodromal
symptoms of schizophrenia with a contemporaneous neuroanatomical deficit (lower y-intercept) may still
be at risk for experiencing later neuromaturational disturbances (aberrant slope) once they become older
adolescents.
Limitations
Although the brain age approach can quantitatively assess deviations in brain maturation at the single
individual level, such deviations are not likely to be specific to a particular disorder. By design, the fitted
model parameters are data driven, characterizing the regularized maturation pattern among brain structures
that tracks with variations in chronological age among typically developing individuals. In other words,
this composite metric is not optimized for detecting risk of schizophrenia per se and would presumably be
sensitive to any condition in which individuals deviate from the normal pattern of age-related
neuroanatomical change during childhood or adolescence. However, the regional brain measures that
contribute heavily to estimating chronological age in a typically developing population (ie, our top 25 hits
as shown in eTable 2 in the Supplement) show considerable overlap with key regions in which prior
studies have shown gray matter differences between CHR individuals who convert to psychosis and those
who do not.  These overlapping regions include regional gray matter volume measures, including the
frontal, temporal, and parietal cortex, as well as hippocampal and amygdala volume.
Training models to predict conversion to psychosis as a categorical outcome seems like an intuitively
appealing approach, but we were not successful in building such models using our data set. The
performance of such models may be limited by the difficulty in adequately accounting for the backdrop of
variation in normative adolescent brain development and the likelihood of heterogeneity in the pathways
leading to full psychosis among individuals at CHR. However, it may be possible to increase the
sensitivity to outcomes on the schizophrenia spectrum by constraining the spatial topologic parameters of
brain age classifiers to brain regions previously associated with risk of psychosis and by incorporating
neuroimaging parameters from other modalities. Eventually, the brain age and outcome-based machine
learning approaches may be combinable with other clinical predictors  to provide added traction on the
problem of predicting the onset of psychosis among CHR individuals. To further validate whether our
findings are in accord with the neurodevelopmental model, additional investigation is required to confirm
1,2,18,19
1,2,14
14,42,43
1,2,18,19
14
14,42,43
44,45,46,47
17,48
49,50
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whether neuroanatomical abnormality among younger CHR individuals is in fact affected by exposure to
early neurodevelopmental risk factors (eg, obstetric complications) and/or present with an insidious onset
in terms of premorbid functioning.
Conclusions
The brain age approach used in this study captured neuromaturational deviation associated with risk of
psychosis only among younger CHR adolescents. This finding and the evidence that only CHR converters
at the age of 18 years or older show a differential rate of progressive neuroanatomical changes over time
are consistent with the view that differing intercepts and trajectories in structural brain parameters as a
function of age contribute to heterogeneity in the timing of the onset and course of schizophrenia.
Notes
Supplement.
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eFigure 2. Bias Adjustment and Generalization
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eFigure 4. Brain Age Gap as an Estimator of Conversion to Psychosis
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Figure 1.
Model of Neurodevelopmental Trajectories of Cortical Synaptic Density in Association With Onset of Psychosis
Possible paths to schizophrenia, with the gradation of colors from yellow to orange representing the increasing severity of
psychotic symptoms.1,2,18,19
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Table.
Demographic Characteristics of Participants
Abbreviations: CHR-C, clinically high-risk individuals who converted to psychosis; CHR-NC, clinically high-risk
individuals who did not convert to psychosis; GAF, Global Assessment of Functioning; HC, healthy controls; NA, not
applicable.
The greater than symbol indicates direction of the significant results.
Parental education scored as follows: 1, no schooling; 2, some primary school; 3, completed primary school; 4, some
high school; 5, completed high school; 6, some college, technical school, or undergraduate education; 7, completed
college, technical school, or undergraduate education; 8, some graduate or professional school; and 9, completed
graduate or professional school.
Characteristic HC (n 
= 109)
CHR-NC
(n = 236)
CHR-C
(n = 39)
Statistical Test for
Significance (2-Tailed)
P
Value
Post Hoc
Tukey Test
Age, mean (SD), y 17.02
(2.44)
17.30
(2.10)
17.20
(2.23)
F = 0.61 .55 NA
Male sex, No. (%) 66
(60.6)
142 (60.2) 23 (59.0) χ  = 0.038 .98 NA
Education level, mean (SD),
y
10.31
(2.44)
10.37
(2.07)
10.35
(2.26)
F = 0.03 .96 NA
Paternal education score,
mean (SD)
6.43
(1.73)
6.14 (1.66) 6.42
(2.01)
F = 1.32 .99 NA
Maternal education score,
mean (SD)
6.87
(1.46)
6.26 (1.52) 6.56
(1.74)
F = 5.94 .003 HC, CHR-C 
> CHR-NC
Race/ethnicity, No. (%)
White 58
(53.2)
151 (64.0) 26 (66.7) χ  = 5.73 .06 NA
Hispanic or Latino 24
(22.0)
40 (16.9) 7 (17.9) χ  = 1.43 .49 NA
Black 24
(22.0)
30 (12.7) 4 (10.3) χ  = 5.46 .07 NA
Asian 8 (7.3) 17 (7.2) 3 (7.7) χ  = 0.14 .99 NA
First Nations 2 (1.8) 5 (2.1) 1 (2.6) χ  = 0.14 .93 NA
Interracial 14
(12.8)
24 (10.2) 3 (7.7) χ  = 0.13 .93 NA
Taking antipsychotics, No.
(%)
0 53 (22.5) 12 (30.8) χ  = 1.25 .26 NA
Scale of Prodromal
Symptoms score, mean
(SD)
Positive 1.14
(1.58)
11.89
(3.59)
13.05
(3.59)
F = 459.8 <.001 CHR-C > 
CHR-NC > 
HC
Negative 1.92
(2 75)
12.11
(6 20)
12.21
(6 28)
F = 134.9 <.001 CHR-C,
CHR-NC >
a
2
b
b
2
2
2
2
2
2
c
2 d
a
b
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Because this was a naturalistic study, individuals were treated in their respective communities according to
prevailing standards and the judgment of the treating clinicians, who were often primary care physicians rather than
psychiatrists.
χ  Test performed within CHR group.
c
d 2
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Figure 2.
Brain Age Model Building, Validation, and Application
A, Cross-validation results within the Pediatric Imaging, Neurocognition, and Genetics (PING) study sample with bias
adjustment. Estimated brain age is plotted as a function of observed chronological age at baseline magnetic resonance
imaging scan. The solid diagonal line indicates linear fit, and the dashed diagonal lines indicate the 95% prediction
interval. Colors correspond to different scanners (R  = 0.84; mean absolute error [MAE] = 1.69 years; mean error = –0.001
year). B, Optimized brain age model trained with the PING sample was applied without modification to the healthy
control (HC), clinically high-risk with no conversion to psychosis (CHR-NC), and clinically high-risk with conversion to
psychosis (CHR-C) individuals in the North American Prodrome Longitudinal Study 2 (NAPLS 2). A significant CHR
group by chronological age interaction was observed (P = .047). Colors correspond to different groups, and the dashed
line indicates where predicted and chronological age perfectly meet (R  = 0.51; MAE = 1.41 years; mean error = –0.06
year). C, Bar plots of mean (SE) brain age gap by diagnostic groups among younger adolescents (<17 years of age). Both
CHR-C individuals and patients with a first episode of psychosis (FE) showed an increased brain age gap compared with
HCs (CHR-C, P = .02; FE = 0.02). The dashed line indicates MAE for brain age model performance in NAPLS 2 HCs. D,
Bar plots of mean (SE) brain age gap by diagnostic groups among older adolescents and young adults (17-21 years of
age). There were no significant differences of brain age gap by group (P > .10). The dashed line indicates MAE for brain
age model performance in NAPLS 2 HCs. All error bars indicate SE.
P < .05, corrected.
2
2
a
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Figure 3.
Course of Functioning From Baseline to 12-Month Follow-up by Brain Age Gap
Global Assessment of Functioning Scale (GAF) scores at baseline and 12-month follow-up among clinically high-risk
individuals according to whether their brain age gap scores were in the expected range vs underestimated or overestimated
using the mean absolute error of the brain age model as a threshold (underestimated: brain age gap < −1.5; expected: −1.5 
≤ brain age gap ≤1.5 years; and overestimated: 1.5 < brain age gap). Mean GAF scores improved from baseline to follow-
up when the brain age gap was within the mean absolute error range (P < .001) but did not improve for individuals with an
underestimated or overestimated brain age gap. Clinically high-risk individuals who converted to psychosis were
disproportionately represented among those with an overestimated brain age gap (underestimated, n = 0; expected, n = 8;
overestimated, n = 9), and a similar pattern was observed even when converters were excluded (eFigure 6 in the
Supplement).
P < .001, corrected.a
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Figure 4.
Annualized Rate of Percentage Change
A, Annualized rate of percentage change in the right superior frontal thickness, plotted as a function of age at baseline. B,
Annualized rate of percentage change in third ventricle volume, plotted as a function of age at baseline. Locally weighted
smoothing curve with 95% CI (colored area) is shown for each diagnostic group. With the use of a generalized linear
model, a significant group (clinically high risk with conversion to psychosis [CHR-C] vs healthy control [HC]) by
chronological age interaction was observed (right superior frontal thickness: P = .03; third ventricle: P = .001). Outliers
defined by studentized deleted residuals exceeding ±3 were excluded (2 HCs, 4 individuals at clinically high risk with no
conversion to psychosis [CHR-NC], and 2 individuals at CHR-C). Further details about demographics, image processing
steps, and principal findings are reported in prior publications.14,42,43
